Skip to content

Public FDA record

Z-1882-2018: Visaris Vision/Auto, ddRAura OTC APS, Diagnostic X-Ray System, Version 2.4 The Vision systems are intend

Recall record Z-1882-2018 for Visaris DOO. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1882-2018
Company in FDA record
Visaris DOO
FDA record creation date
May 15, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

A failure of the tube arm suspension is possible while the tube arm height is being adjusted. During tube height adjustment there is a small probability of failure of both the primary and redundant holding mechanisms, causing uncontrollable descent of the tube arm and a potential risk of injury to the patient.

Source facts

Action
Notification letters instruct users to perform the following actions: System end users should: Sign and return the Acknowledgement Form (part of this document). allow Visaris authorized service engineers access to perform the scheduled upgrade and refresher user training Read and familiarize themselves with the current user manual for Vision C devices and safety guidelines provided therein. Within the next four weeks Visaris will prepare and deliver an improved version of the elevation column mechanism for the Vision C devices to all relevant authorized distributors and service organizations. Visaris distributors will get in touch with you to initiate and agree a schedule of the field upgrade. Visaris engineers will at scheduled times upgrade the column mechanisms, including complete site acceptance and additional safety testing on all upgraded devices. During this activity users will be provided with the latest version of user manual and re-fresher system use training. This notice and relevant end user action information needs to be passed on to all system end user organizations. Please acknowledge receipt of this notification and maintain awareness of this notice and resulting actions for a period of three months to ensure effectiveness of the upgrade actions. For further questions, please call (239) 234-1735.
Initiated
2018-04-05
Root cause
Other
Terminated
2019-09-19
Distribution
Worldwide Distribution - US Distribution to the states of : FL, LA, MD, MS, NJ, and NY., and to the countries of : Czech Republic, Germany, Serbia, Switzerland, Taiwan, and United Kingdom.
Recall number
Z-1882-2018
Recall status
Terminated
CDRH record ID
163926
FDA record created
2018-05-15
Recall event number
79848

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗